Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer
HSP90 抑制剂 Ganetespib 用于 II/III 期乳腺癌新辅助治疗的安全性和有效性
期刊:NPJ Breast Cancer
影响因子:6.5
doi:10.1038/s41523-022-00493-z
Julie E Lang, Andres Forero-Torres, Douglas Yee, Christina Yau, Denise Wolf, John Park, Barbara A Parker, A Jo Chien, Anne M Wallace, Rashmi Murthy, Kathy S Albain, Erin D Ellis, Heather Beckwith, Barbara B Haley, Anthony D Elias, Judy C Boughey, Rachel L Yung, Claudine Isaacs, Amy S Clark, Hyo S Ha